Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Jacobson

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Oncologist|March 29, 2022
Benefits of Adjuvant Chemotherapy Differ by Menopausal Status in Women with HR+/HER2- Early Breast Cancer, 1-3 Positive Nodes, and a Low Recurrence ScoreAnne Jacobson
The Oncologist|March 29, 2022
Pyrotinib Improves Survival in Previously Treated HER2-Positive Metastatic Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Ribociclib Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer Across Common Genomic and Clinical SubtypesAnne Jacobson
The Oncologist|March 29, 2022
Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain MetastasesAnne Jacobson
The Oncologist|March 29, 2022
SABCS 2021 Insights on Breast Cancer Research: An Interview with Dr. Laura SpringAnne Jacobson
JAMA|March 15, 2018
The Cicada SeasonAnne Jacobson
The Oncologist|March 29, 2022
Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Early Switch to Fulvestrant Plus Palbociclib Improves Outcomes in ESR1-Mutated, Estrogen Receptor-Positive Metastatic Breast CancerAnne Jacobson
JAMA|November 19, 2009
A piece of my mind. Going homeAnne Jacobson
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Oncologist|March 29, 2022
Benefits of Adjuvant Chemotherapy Differ by Menopausal Status in Women with HR+/HER2- Early Breast Cancer, 1-3 Positive Nodes, and a Low Recurrence ScoreAnne Jacobson
The Oncologist|March 29, 2022
Pyrotinib Improves Survival in Previously Treated HER2-Positive Metastatic Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Ribociclib Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer Across Common Genomic and Clinical SubtypesAnne Jacobson
The Oncologist|March 29, 2022
Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain MetastasesAnne Jacobson
The Oncologist|March 29, 2022
SABCS 2021 Insights on Breast Cancer Research: An Interview with Dr. Laura SpringAnne Jacobson
JAMA|March 15, 2018
The Cicada SeasonAnne Jacobson
The Oncologist|March 29, 2022
Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast CancerAnne Jacobson
The Oncologist|March 29, 2022
Early Switch to Fulvestrant Plus Palbociclib Improves Outcomes in ESR1-Mutated, Estrogen Receptor-Positive Metastatic Breast CancerAnne Jacobson
JAMA|November 19, 2009
A piece of my mind. Going homeAnne Jacobson
Pageof 3